SRPT stock news
This page provides real-time market news, earnings updates, and company announcements related to Sarepta Therapeutics, Inc. (SRPT).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-03-25 07:19 EST
Sarepta Therapeutics (SRPT) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Finviz2026-02-18 16:04:05
Sarepta Therapeutics: Fourth Quarter Earnings Overview
101 finance2026-02-25 21:51:07
新浪财经2026-02-26 10:35:02
Sarepta Drops 8.9%: The Biotech Sector's Unpredictable Journey Through Innovation and Risk
101 finance2026-02-26 15:31:26
Sarepta Therapeutics, Inc. (SRPT): A Bull Case Theory
Finviz2026-02-28 17:01:08
Wells Fargo Cuts PT on Sarepta Therapeutics (SRPT) to $38 From $45
Finviz2026-03-01 09:30:11
Can Keros Therapeutics' Rinvatercept Distinguish Itself in the DMD Marketplace?
101 finance2026-03-06 18:10:09
FDA’s Top Vaccine Official Vinay Prasad Will Step Down From His Role Next Month
101 finance2026-03-06 23:27:16
Why Is uniQure Stock Skyrocketing Monday?
Finviz2026-03-09 11:06:50
What's Going On With Moderna, Capricor, Other Biotech Stocks On Monday?
Finviz2026-03-09 17:33:53
SRPT Stock Rises as DMD Gene Therapy Safety Trial Kicks Off
101 finance2026-03-17 15:43:06
KROS Stock: Key Information on Rinvatercept for DMD
101 finance2026-03-17 18:27:50
KROS: Does the Discounted Book Value Represent a Value Trap?
101 finance2026-03-17 18:27:51
KROS Pipeline Catalysts: DMD Phase II Progress and ALS Strategy for 2026
101 finance2026-03-17 18:27:52
The U.S. Food and Drug Administration (FDA) has officially approved Sarepta Therapeutics to submit its Essence clinical research data and real-world evidence as key materials supporting its Supplemental New Drug Applications (SNDAs).
老虎证券2026-03-19 13:17:07
Taysha (TSHA) Fourth Quarter 2025 Earnings Conference Call Transcript
101 finance2026-03-19 14:28:19
Sarepta's Elevidys Pause Creates Survival Test as Market Ignores sNDA Noise
101 finance2026-03-19 18:03:57
2 Undervalued Stocks That Remain Unattractive for Investment
101 finance2026-03-21 20:27:16
Canopy Growth and Sarepta Therapeutics: The Market’s Deeply Discounted Outlook Could Spell Trouble for Value Investors
101 finance2026-03-21 20:48:51
Sarepta Therapeutics, Inc. (SRPT): A Bull Case Theory
Finviz2026-02-28 17:01:08
Wells Fargo Cuts PT on Sarepta Therapeutics (SRPT) to $38 From $45
Finviz2026-03-01 09:30:11
Can Keros Therapeutics' Rinvatercept Distinguish Itself in the DMD Marketplace?
101 finance2026-03-06 18:10:09
FDA’s Top Vaccine Official Vinay Prasad Will Step Down From His Role Next Month
101 finance2026-03-06 23:27:16
Why Is uniQure Stock Skyrocketing Monday?
Finviz2026-03-09 11:06:50
What's Going On With Moderna, Capricor, Other Biotech Stocks On Monday?
Finviz2026-03-09 17:33:53
SRPT Stock Rises as DMD Gene Therapy Safety Trial Kicks Off
101 finance2026-03-17 15:43:06
KROS Stock: Key Information on Rinvatercept for DMD
101 finance2026-03-17 18:27:50
KROS: Does the Discounted Book Value Represent a Value Trap?
101 finance2026-03-17 18:27:51
KROS Pipeline Catalysts: DMD Phase II Progress and ALS Strategy for 2026
101 finance2026-03-17 18:27:52
The U.S. Food and Drug Administration (FDA) has officially approved Sarepta Therapeutics to submit its Essence clinical research data and real-world evidence as key materials supporting its Supplemental New Drug Applications (SNDAs).
老虎证券2026-03-19 13:17:07
Taysha (TSHA) Fourth Quarter 2025 Earnings Conference Call Transcript
101 finance2026-03-19 14:28:19
Sarepta's Elevidys Pause Creates Survival Test as Market Ignores sNDA Noise
101 finance2026-03-19 18:03:57
2 Undervalued Stocks That Remain Unattractive for Investment
101 finance2026-03-21 20:27:16
Canopy Growth and Sarepta Therapeutics: The Market’s Deeply Discounted Outlook Could Spell Trouble for Value Investors
101 finance2026-03-21 20:48:51
SRPT stock chart
SRPT stock detailsSRPT stock price change
On the last trading day, SRPT stock closed at 17.64 USD, with a price change of -0.42% for the day.
Trade stock perpsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more